Abstract
Human mesenchymal stem cells (hMSCs) are a valuable source of cells for clinical applications (e.g., treatment of acute myocardial infarction or inflammatory diseases), especially in the field of regenerative medicine. However, for autologous (patient-specific) and allogeneic (off-the-shelf) hMSC-based therapies, in vitro expansion is necessary prior to the clinical application in order to achieve the required cell numbers. Safe, reproducible, and economic in vitro expansion of hMSCs for autologous and allogeneic therapies can be problematic because the cell material is restricted and the cells are sensitive to environmental changes. It is beneficial to collect detailed information on the hydrodynamic conditions and cell growth behavior in a bioreactor system, in order to develop a so called “Digital Twin” of the cultivation system and expansion process. Numerical methods, such as Computational Fluid Dynamics (CFD) which has become widely used in the biotech industry for studying local characteristics within bioreactors or kinetic growth modelling, provide possible solutions for such tasks.
In this review, we will present the current state-of-the-art for the in vitro expansion of hMSCs. Different numerical tools, including numerical fluid flow simulations and cell growth modelling approaches for hMSCs, will be presented. In addition, a case study demonstrating the applicability of CFD and kinetic growth modelling for the development of an microcarrier-based hMSC process will be shown.
Graphical Abstract
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CC:
-
Collagen-coated
- CFD:
-
Computational Fluid Dynamics
- DMEM:
-
Dulbecco’s Modified Eagle Medium
- DSP:
-
Downstream processing
- ECM:
-
Extracellular matrix
- bFGF:
-
Basic fibroblast growth factor
- FBS:
-
Fetal bovine serum
- GMP:
-
Good manufacturing practice
- hASC:
-
Human adipose tissue-derived stromal/stem cells
- hBM-MSC:
-
Human bone marrow-derived mesenchymal stem cells
- hMSCs:
-
Human mesenchymal stem cells
- hPL:
-
Human platelet lysate
- HGF:
-
Hepatocyte growth factor
- HSB:
-
Hemispherical-bottom bioreactor
- LDA:
-
Laser Doppler Anemometry
- LES:
-
Large Eddy Simulations
- αMEM:
-
Modified Eagle Medium
- MC:
-
Microcarrier
- MCB:
-
Master Cell Bank
- MRF:
-
Moving reference frame
- OTR:
-
Oxygen transfer rate
- PIV:
-
Particle Image Velocimetry
- PS:
-
Polystyrene-based
- RB:
-
Round-bottom bioreactor
- RMSD:
-
Root mean square deviation
- SIMPLE:
-
Semi-implicit method for pressure-linked equations
- SM:
-
Sliding mesh
- SU:
-
Single use
- UCM:
-
Umbilical cord-derived mesenchymal stem cells
- USP:
-
Upstream processing
- VEGF:
-
Vascular endothelial growth factor
- VOF:
-
Volume of fluid
- WCB:
-
Working Cell Bank
- Amn (mmol/L):
-
Ammonium concentration
- DO2 (m2/s):
-
Oxygen diffusivity
- DR (m):
-
Vessel diameter
- EF :
-
Expansion factor
- F (N):
-
Force
- Glc (mmol/L):
-
Glucose concentration
- h/H L :
-
Geometrical ratio between a certain height and the liquid height
- h R /D R :
-
Geometrical ratio between impeller installation height and the vessel diameter (= off-bottom clearance)
- HL (m):
-
Liquid height
- H L /D :
-
Geometrical ratio between liquid height and vessel diameter
- kat (d-1):
-
Cell attachment constant
- kdet (d-1):
-
Cell detachment constant
- KAmn (mmol/L):
-
Inhibition constant of ammonium
- KGlc (mmol/L):
-
Monod constant of glucose
- KLac (mmol/L):
-
Inhibition constant of lactate
- Lac (mmol/L):
-
Lactate concentration
- N (rpm):
-
Impeller speed
- Ns1u (rpm):
-
Lower limit of Ns1 suspension criterion
- Ns1 (rpm):
-
1s or just suspended criterion (=Njs)
- PDL :
-
Population doubling level
- P/V (W/m3):
-
Specific (volumetric) power input
- pAmn (mmol/cell/d):
-
Specific ammonium production rate (growth-independent)
- pLac (mmol/cell/d):
-
Specific lactate production rate (growth-independent)
- qAmn (mmol/cell/d):
-
Specific ammonium production rate (growth-dependent)
- qGlc (mmol/cell/d):
-
Specific glucose consumption rate
- qLac (mmol/cell/d):
-
Specific lactate production rate (growth-dependent)
- Re :
-
Reynolds number
- r/R :
-
Dimensionless radial coordinates
- tc (s):
-
Contact time
- tcir (s):
-
Particle circulation times
- td (d):
-
Doubling time of cell population
- tl (d):
-
Lag or cell adaption time
- tres (s):
-
Particle residence time
- utip (m/s):
-
Impeller tip speed
- \( \overrightarrow{u} \)(m/s):
-
Velocity vector in x-direction
- Vmin (mL):
-
Minimal working volume
- Vmax (mL):
-
Maximum working volume
- \( \overrightarrow{v\ } \) (m/s):
-
Velocity vector in y-direction
- \( \overrightarrow{w} \)(m/s):
-
Velocity vector in z-direction
- XA (cells/cm2):
-
Cell concentration on surface
- Xmax (cells/cm2):
-
Maximum cell concentration on surface
- XSus (cells/mL):
-
Cell concentration in suspension
- XV (cells/cm2):
-
Cell concentration of viable cells (XSus + XA)
- YLac/Glc (mmol/mmol):
-
Lactate yield per glucose equivalent
- YX/O2 (1/mmol):
-
Yield coefficient/cells per mmol oxygen
- α :
-
Cell adaption phase coefficient
- α MC :
-
MC volume fraction
- δ Glc :
-
Step response in glucose balance to avoid negative glucose values (δGlc = 0 or 1)
- ηL (Pa s):
-
Dynamic viscosity of the liquid
- π :
-
Mathematical constant (≈ 3.1415)
- ρL (kg/m3):
-
Density of the liquid
- τnn (Pa):
-
Local normal stress
- τnt (Pa):
-
Local shear stress
- μ (1/d):
-
Specific growth rate
- μmax (1/d):
-
Maximum specific growth rate
References
Grand View Research (2020) Cell therapy market size, share and trends analysis report, 2020–2027
Malik NN, Durdy MB (2015) Cell therapy landscape. In: Translational regenerative medicine. Elsevier, pp 87–106
Simaria AS, Hassan S, Varadaraju H, Rowley J, Warren K, Vanek P, Farid SS (2014) Allogeneic cell therapy bioprocess economics and optimization: single-use cell expansion technologies. Biotechnol Bioeng 111:69–83. https://doi.org/10.1002/bit.25008
Sharma S, Raju R, Sui S, Hu W-S (2011) Stem cell culture engineering – process scale up and beyond. Biotechnol J 6:1317–1329. https://doi.org/10.1002/biot.201000435
Ren G, Chen X, Dong F, Li W (2012) Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem Cells Transl Med 1:51–58
Capelli C, Pedrini O, Valgardsdottir R, Da Roit F, Golay J, Introna M (2015) Clinical grade expansion of MSCs. Immunol Lett 168:222–227. https://doi.org/10.1016/j.imlet.2015.06.006
Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, Benes V, Blake J, Pfister S, Eckstein V, Ho AD (2008) Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 3:e2213. https://doi.org/10.1371/journal.pone.0002213
Lo Surdo J, Bauer SR (2012) Quantitative approaches to detect donor and passage differences in adipogenic potential and clonogenicity in human bone marrow-derived mesenchymal stem cells. Tissue Eng Part C Methods 18:877–889. https://doi.org/10.1089/ten.tec.2011.0736
Heathman TRJ, Rafiq QA, Chan AKC, Coopman K, Nienow AW, Kara B, Hewitt CJ (2016) Characterization of human mesenchymal stem cells from multiple donors and the implications for large scale bioprocess development. Biochem Eng J 108:14–23. https://doi.org/10.1016/j.bej.2015.06.018
Das R, Roosloot R, van Pel M, Schepers K, Driessen M, Fibbe WE, de Bruijn JD, Roelofs H (2019) Preparing for cell culture scale-out: establishing parity of bioreactor- and flask-expanded mesenchymal stromal cell cultures. J Transl Med 17:241. https://doi.org/10.1186/s12967-019-1989-x
Jossen V, Schirmer C, Mostafa Sindi D, Eibl R, Kraume M, Pörtner R, Eibl D (2016) Theoretical and practical issues that are relevant when scaling up hMSC microcarrier production processes. Stem Cells Int 2016:1–15. https://doi.org/10.1155/2016/4760414
Jossen V, Eibl R, Kraume M, Eibl D (2018) Growth behavior of human adipose tissue-derived stromal/stem cells at small scale: numerical and experimental investigations. Bioengineering 5:106. https://doi.org/10.3390/bioengineering5040106
Hassan S, Simaria AS, Varadaraju H, Gupta S, Warren K, Farid SS (2015) Allogeneic cell therapy bioprocess economics and optimization: downstream processing decisions. Regen Med 10:591–609
Lipsitz YY, Milligan WD, Fitzpatrick I, Stalmeijer E, Farid SS, Tan KY, Smith D, Perry R, Carmen J, Chen A, Mooney C, Fink J (2017) A roadmap for cost-of-goods planning to guide economic production of cell therapy products. Cytotherapy 19:1383–1391. https://doi.org/10.1016/j.jcyt.2017.06.009
García-Fernández C, López-Fernández A, Borrós S, Lecina M, Vives J (2020) Strategies for large-scale expansion of clinical-grade human multipotent mesenchymal stromal cells. Biochem Eng J 159:107601. https://doi.org/10.1016/j.bej.2020.107601
Dolley-Sonneville P, Melkoumian Z, Romeo L. Corning® Stemgro® hMSC Medium. Corning Appl Note 1–8
Gottipamula S, Muttigi MS, Chaansa S, Ashwin KM, Priya N, Kolkundkar U, Sundar Raj S, Sen MA, Seetharam RN (2016) Large-scale expansion of pre-isolated bone marrow mesenchymal stromal cells in serum-free conditions. J Tissue Eng Regen Med 10:108–119. https://doi.org/10.1002/term.1713
Carter SM, Granchelli J, Stelzer T (2014) Large scale expansion and differentiation of human mesenchymal stromal cells in the Thermo Scientific nunc cell factory system. Thermo Sci Appl Note 1:1–6
Jossen V, Muoio F, Panella S, Harder Y, Tallone T, Eibl R (2020) An approach towards a GMP compliant in-vitro expansion of human adipose stem cells for autologous therapies. Bioengineering 7(3):77–100
Reichardt A, Polchow B, Shakibaei M, Henrich W, Hetzer R, Lueders C (2013) Large scale expansion of human umbilical cord cells in a rotating bed system bioreactor for cardiovascular tissue engineering applications. Open Biomed Eng J 7:50–61. https://doi.org/10.2174/1874120701307010050
Ikebe C, Suzuki K (2014) Mesenchymal stem cells for regenerative therapy: optimization of cell preparation protocols. Biomed Res Int 2014:1–11. https://doi.org/10.1155/2014/951512
Scibona E, Morbidelli M (2019) Expansion processes for cell-based therapies. Biotechnol Adv 37:107455. https://doi.org/10.1016/j.biotechadv.2019.107455
Discher DE, Mooney DJ, Zandstra PW (2010) Growth factors, matrices, and forces combine. Growth (Lakeland) 324:1673–1677. https://doi.org/10.1126/science.1171643.Growth
Steward AJ, Kelly DJ (2015) Mechanical regulation of mesenchymal stem cell differentiation. J Anat 227:717–731. https://doi.org/10.1111/joa.12243
Kaiser SC, Eibl D, Eibl R (2015) Single-use bioreactors for animal and human cells. In: Animal cell culture: cell engineering. Springer, Cham, pp 445–499
Baraniak PR, McDevitt TC (2012) Scaffold-free culture of mesenchymal stem cell spheroids in suspension preserves multilineage potential. Cell Tissue Res 347:701–711. https://doi.org/10.1007/s00441-011-1215-5
Frith JE, Thomson B, Genever PG (2010) Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng Part C Methods 16:735–749. https://doi.org/10.1089/ten.tec.2009.0432
Alimperti S, Lei P, Wen Y, Tian J, Campbell AM, Andreadis ST (2014) Serum-free spheroid suspension culture maintains mesenchymal stem cell proliferation and differentiation potential. Biotechnol Prog 30:974–983. https://doi.org/10.1002/btpr.1904
Allen LM, Matyas J, Ungrin M, Hart DA, Sen A (2019) Serum-free culture of human mesenchymal stem cell aggregates in suspension bioreactors for tissue engineering applications. Stem Cells Int 2019:1–18. https://doi.org/10.1155/2019/4607461
Bhang SH, Cho S-W, La W-G, Lee T-J, Yang HS, Sun A-Y, Baek S-H, Rhie J-W, Kim B-S (2011) Angiogenesis in ischemic tissue produced by spheroid grafting of human adipose-derived stromal cells. Biomaterials 32:2734–2747. https://doi.org/10.1016/j.biomaterials.2010.12.035
Layer PG, Robitzki A, Rothermel A, Willbold E (2002) Of layers and spheres: the reaggregate approach in tissue engineering. Trends Neurosci 25:131–134. https://doi.org/10.1016/S0166-2236(00)02036-1
Achilli T-M, Meyer J, Morgan JR (2012) Advances in the formation, use and understanding of multi-cellular spheroids. Expert Opin Biol Ther 12:1347–1360. https://doi.org/10.1517/14712598.2012.707181
Page H, Flood P, Reynaud EG (2013) Three-dimensional tissue cultures: current trends and beyond. Cell Tissue Res 352:123–131. https://doi.org/10.1007/s00441-012-1441-5
Edmondson R, Broglie JJ, Adcock AF, Yang L (2014) Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol 12:207–218. https://doi.org/10.1089/adt.2014.573
Caron MMJ, Emans PJ, Coolsen MME, Voss L, Surtel DAM, Cremers A, van Rhijn LW, Welting TJM (2012) Redifferentiation of dedifferentiated human articular chondrocytes: comparison of 2D and 3D cultures. Osteoarthr Cartil 20:1170–1178. https://doi.org/10.1016/j.joca.2012.06.016
Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, Redl H, Rubin JP, Yoshimura K, Gimble JM (2013) Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International So. Cytotherapy 15:641–648. https://doi.org/10.1016/j.jcyt.2013.02.006
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317. https://doi.org/10.1080/14653240600855905
Cheng N-C, Chen S-Y, Li J-R, Young T-H (2013) Short-term spheroid formation enhances the regenerative capacity of adipose-derived stem cells by promoting stemness, angiogenesis, and chemotaxis. Stem Cells Transl Med 2:584–594. https://doi.org/10.5966/sctm.2013-0007
Bartosh TJ, Ylostalo JH, Mohammadipoor A, Bazhanov N, Coble K, Claypool K, Lee RH, Choi H, Prockop DJ (2010) Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci 107:13724–13729. https://doi.org/10.1073/pnas.1008117107
YlÖstalo JH, Bartosh TJ, Coble K, Prockop DJ (2012) Human mesenchymal stem/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype. Stem Cells 30:2283–2296. https://doi.org/10.1002/stem.1191
Zimmermann JA, Mcdevitt TC (2014) Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion. Cytotherapy 16:331–345. https://doi.org/10.1016/j.jcyt.2013.09.004
Horn P, Bokermann G, Cholewa D, Bork S, Walenda T, Koch C, Drescher W, Hutschenreuther G, Zenke M, Ho AD, Wagner W (2010) Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells. Cytotherapy 12:888–898. https://doi.org/10.3109/14653249.2010.501788
Badenes SM, Fernandes TG, Rodrigues CAV, Diogo MM, Cabral JMS (2016) Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems. J Biotechnol 234:71–82. https://doi.org/10.1016/j.jbiotec.2016.07.023
Villa-Diaz LG, Ross AM, Lahann J, Krebsbach PH (2013) Concise review: the evolution of human pluripotent stem cell culture: from feeder cells to synthetic coatings. Stem Cells 31:1–7. https://doi.org/10.1002/stem.1260
Shearier E, Xing Q, Qian Z, Zhao F (2016) Physiologically low oxygen enhances biomolecule production and stemness of mesenchymal stem cell spheroids. Tissue Eng Part C Methods 22:360–369. https://doi.org/10.1089/ten.tec.2015.0465
Wu J, Rostami MR, Cadavid Olaya DP, Tzanakakis ES (2014) Oxygen transport and stem cell aggregation in stirred-suspension bioreactor cultures. PLoS One 9:e102486. https://doi.org/10.1371/journal.pone.0102486
Lei Y, Schaffer DV (2013) A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation. Proc Natl Acad Sci 110:E5039–E5048. https://doi.org/10.1073/pnas.1309408110
Sart S, Tsai A-C, Li Y, Ma T (2014) Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties, and applications. Tissue Eng Part B Rev 20:365–380. https://doi.org/10.1089/ten.teb.2013.0537
Sucosky P, Osorio DF, Brown JB, Neitzel GP (2004) Fluid mechanics of a spinner-flask bioreactor. Biotechnol Bioeng 85:34–46. https://doi.org/10.1002/bit.10788
Kaiser S, Jossen V, Schirmaier C, Eibl D, Brill S, van den Bos C, Eibl R (2013) Fluid flow and cell proliferation of mesenchymal adipose-derived stem cells in small-scale, stirred, single-use bioreactors. Chem Ing Tech 85:95–102. https://doi.org/10.1002/cite.201200180
vn Wezel AL (1967) Growth of cell-strains and primary cells on microcarriers in homogeneous culture. Nature 216:64–65
Chen AK-L, Reuveny S, Oh SKW (2013) Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: achievements and future direction. Biotechnol Adv 31:1032–1046. https://doi.org/10.1016/j.biotechadv.2013.03.006
Jossen V, van den Bos C, Eibl R, Eibl D (2018) Manufacturing human mesenchymal stem cells at clinical scale: process and regulatory challenges. Appl Microbiol Biotechnol 102:3981–3994. https://doi.org/10.1007/s00253-018-8912-x
Rafiq QA, Ruck S, Hanga MP, Heathman TRJ, Coopman K, Nienow AW, Williams DJ, Hewitt CJ (2018) Qualitative and quantitative demonstration of bead-to-bead transfer with bone marrow-derived human mesenchymal stem cells on microcarriers: utilising the phenomenon to improve culture performance. Biochem Eng J 135:11–21. https://doi.org/10.1016/j.bej.2017.11.005
Leber J, Barekzai J, Blumenstock M, Pospisil B, Salzig D, Czermak P (2017) Microcarrier choice and bead-to-bead transfer for human mesenchymal stem cells in serum-containing and chemically defined media. Process Biochem 59:255–265. https://doi.org/10.1016/j.procbio.2017.03.017
Szczypka M, Splan D, Woolls H, Brandwein H (2014) Single-use bioreactors and microcarriers. Bioprocess Int 12:54–64
Zhao L-G, Chen S-L, Teng Y-J, An L-P, Wang J, Ma J-L, Xia Y-Y (2014) The MEK5/ERK5 pathway mediates fluid shear stress promoted osteoblast differentiation. Connect Tissue Res 55:96–102. https://doi.org/10.3109/03008207.2013.853755
Yim EK, Sheetz MP (2012) Force-dependent cell signaling in stem cell differentiation. Stem Cell Res Ther 3:41. https://doi.org/10.1186/scrt132
Frauenschuh S, Reichmann E, Ibold Y, Goetz PM, Sittinger M, Ringe J (2007) A microcarrier-based cultivation system for expansion of primary mesenchymal stem cells. Biotechnol Prog 23:187–193. https://doi.org/10.1021/bp060155w
Panchalingam KM, Jung S, Rosenberg L, Behie LA (2015) Bioprocessing strategies for the large-scale production of human mesenchymal stem cells: a review. Stem Cell Res Ther 6:225. https://doi.org/10.1186/s13287-015-0228-5
Ferrari C, Balandras F, Guedon E, Olmos E, Chevalot I, Marc A (2012) Limiting cell aggregation during mesenchymal stem cell expansion on microcarriers. Biotechnol Prog 28:780–787. https://doi.org/10.1002/btpr.1527
Schirmaier C, Jossen V, Kaiser SC, Jüngerkes F, Brill S, Safavi-Nab A, Siehoff A, van den Bos C, Eibl D, Eibl R (2014) Scale-up of adipose tissue-derived mesenchymal stem cell production in stirred single-use bioreactors under low-serum conditions. Eng Life Sci 14:292–303. https://doi.org/10.1002/elsc.201300134
Lawson T, Kehoe DE, Schnitzler AC, Rapiejko PJ, Der KA, Philbrick K, Punreddy S, Rigby S, Smith R, Feng Q, Murrell JR, Rook MS (2017) Process development for expansion of human mesenchymal stromal cells in a 50L single-use stirred tank bioreactor. Biochem Eng J 120:49–62. https://doi.org/10.1016/j.bej.2016.11.020
Gruber R, Karreth F, Kandler B, Fuerst G, Rot A, Fischer AB (2004) Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cell under in vitro conditions. Platelets 15:29–35
Lange C, Cakiroglu F, Spiess AN, Cappallo-Obermann H, Dierlamm J, Zander AR (2007) Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 213:18–26
Abdelrazik H, Spaggiari GM, Chiossone L, Mretta L (2011) Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function. Eur J Immunol 41:3281–3290
Heathman TRJJ, Glyn VAM, Picken A, Rafiq QA, Coopman K, Nienow AW, Kara B, Hewitt CJ (2015) Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum-free microcarrier process. Biotechnol Bioeng 112:1696–1707. https://doi.org/10.1002/bit.25582
Carmelo JG, Fernandes-Platzgummer A, Diogo MM, da Silva CL, Cabral JMS (2015) A xeno-free microcarrier-based stirred culture system for the scalable expansion of human mesenchymal stem/stromal cells isolated from bone marrow and adipose tissue. Biotechnol J 10:1235–1247. https://doi.org/10.1002/biot.201400586
Rafiq QA, Coopman K, Nienow AW, Hewitt CJ (2016) Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactors. Biotechnol J 11:473–486. https://doi.org/10.1002/biot.201400862
Heathman TRJ, Stolzing A, Fabian C, Rafiq QA, Coopman K, Nienow AW, Kara B, Hewitt CJ (2016) Scalability and process transfer of mesenchymal stromal cell production from monolayer to microcarrier culture using human platelet lysate. Cytotherapy 18:523–535. https://doi.org/10.1016/j.jcyt.2016.01.007
Nienow AW, Hewitt CJ, Heathman TRJ, Glyn VAM, Fonte GN, Hanga MP, Coopman K, Rafiq QA (2016) Agitation conditions for the culture and detachment of hMSCs from microcarriers in multiple bioreactor platforms. Biochem Eng J 108:24–29. https://doi.org/10.1016/j.bej.2015.08.003
Dufey V, Tacheny A, Art M, Becken U, De Longueville F (2016) Expansion of human bone marrow-derived mesenchymal stem cells in BioBLU 0.3c single-use bioreactors. Appl Note 305:1–8
Heathman TRJ, Nienow AW, Rafiq QA, Coopman K, Bo K, Hewitt CJ (2019) Development of a process control strategy for the serum-free microcarrier expansion of human mesenchymal stem cells towards cost-effective and commercially viable manufacturing. Biochem Eng J 141:200–209. https://doi.org/10.1016/j.bej.2018.10.018
Jossen V, Kaiser SC, Schirmaier C, Herrmann J, Tappe A, Eibl D, Siehoff A, van d BC, Eibl R (2014) Modification and qualification of a stirred single-use bioreactor for the improved expansion of human mesenchymal stem cells at benchtop scale. Pharm Bioprocess 2:311–322. https://doi.org/10.4155/pbp.14.29
Jossen V, Pörtner R, Kaiser SC, Kraume M, Eibl D, Eibl R (2014) Mass production of mesenchymal stem cells – impact of bioreactor design and flow conditions on proliferation and differentiation. In: Eberli D (ed) Cells and biomaterials in regenerative medicine. InTech, Rijeka, pp 119–174
Siddiquee K, Sha M (2014) Large-scale production of human mesenchymal stem cells in BioBLU 5c single-use vessels
Berry JD, Liovic P, Šutalo ID, Stewart RL, Glattauer V, Meagher L (2016) Characterisation of stresses on microcarriers in a stirred bioreactor. App Math Model 40:6787–6804. https://doi.org/10.1016/j.apm.2016.02.025
Paschedag AR (2004) CFD in der Vevfahrenstechnik. Wiley-VCH Verlag GmbH & Co.
Ferziger JH, Peric M, Leonard A (1997) Computational methods for fluid dynamics. Phys Today 50:80–84. https://doi.org/10.1063/1.881751
Rodriguez S (2019) Applied computational fluid dynamics and turbulence modeling. Springer International Publishing, Cham
Delafosse A, Collignon M-L, Marc A, Toye D, Olmos E (2015) Revisiting the determination of hydromechanical stresses encountered by microcarriers in stem cell culture bioreactors. BMC Proc 9:P41. https://doi.org/10.1186/1753-6561-9-S9-P41
Liovic P, Šutalo ID, Stewart R, Glattauer V, Meagher L (2012) Fluid flow and stresses on microcarriers in spinner flask bioreactors. Ninth Int Conf CFD Miner Process Ind:1–6
Delafosse A, Calvo S, Collignon M-L, Delvigne F, Crine M, Toye D (2015) Euler–Lagrange approach to model heterogeneities in stirred tank bioreactors – comparison to experimental flow characterization and particle tracking. Chem Eng Sci 134:457–466. https://doi.org/10.1016/j.ces.2015.05.045
Nienow AW, Rielly CD, Brosnan K, Bargh N, Lee K, Coopman K, Hewitt CJ (2013) The physical characterisation of a microscale parallel bioreactor platform with an industrial CHO cell line expressing an IgG4. Biochem Eng J 76:25–36. https://doi.org/10.1016/j.bej.2013.04.011
Collignon M-L, Delafosse A, Calvo S, Martin C, Marc A, Toye D, Olmos E (2016) Large-Eddy simulations of microcarrier exposure to potentially damaging eddies inside mini-bioreactors. Biochem Eng J 108:30–43. https://doi.org/10.1016/j.bej.2015.10.020
Kunas KT, Papoutsakis ET (1990) The protective effect of serum against hydrodynamic damage of hybridoma cells in agitated and surface-aerated bioreactors. J Biotechnol 15:57–69. https://doi.org/10.1016/0168-1656(90)90051-C
Michaels JD, Petersen JF, Mclntire LV, Papoutsakis ET (1991) Protection mechanisms of freely suspended animal cells (CRL 8018) from fluid-mechanical injury. Viscometric and bioreactor studies using serum, pluronic F68 and polyethylene glycol. Biotechnol Bioeng 38:169–180. https://doi.org/10.1002/bit.260380209
Chisti Y (2000) Animal-cell damage in sparged bioreactors. Trends Biotechnol 18:420–432. https://doi.org/10.1016/S0167-7799(00)01474-8
Jossen V (2020) Bioengineering aspects of microcarrier-based hMSC expansions in different single-use bioreactors. Technical University of Berlin, Berlin
Stoots CM, Calabrese RV (1995) Mean velocity field to a rushton turbine blade. Am Inst Chem Eng J 41:1–11
Wollny S (2010) Experimentelle und numerische Untersuchungen zur Partikelbeanspruchung in gerührten (Bio-)Reaktoren. Technical University of Berlin
Venkat RV, Stock LR, Chalmers JJ (2000) Study of hydrodynamics in microcarrier culture spinner vessels: a particle tracking velocimetry approach. Biotechnol Bioeng 49:456–466. https://doi.org/10.1002/(SICI)1097-0290(19960220)49:4<456::AID-BIT13>3.0.CO;2-8
Ismadi M-Z, Hourigan K, Fouras A (2014) Experimental characterisation of fluid mechanics in a spinner flask bioreactor. Processes 2:753–772. https://doi.org/10.3390/pr2040753
Zhang H, Lamping SR, Pickering SCR, Lye GJ, Shamlou PA (2008) Engineering characteristics of a single well from 24-well and 96-well microtire plates. Biochem Eng J 40:138–149
Godara P, McFarland CD, Nordon RE (2008) Design of bioreactors for mesenchymal stem cell tissue engineering. J Chem Technol Biotechnol 83:408–420. https://doi.org/10.1002/jctb.1918
Rafiq QA, Brosnan KM, Coopman K, Nienow AW, Hewitt CJ (2013) Culture of human mesenchymal stem cells on microcarriers in a 5 l stirred-tank bioreactor. Biotechnol Lett 35:1233–1245. https://doi.org/10.1007/s10529-013-1211-9
Ibrahim S, Nienow AW (2004) Suspension of microcarriers for cell culture with axial flow impellers. Chem Eng Res Des 82:1082–1088. https://doi.org/10.1205/cerd.82.9.1082.44161
Hewitt CJ, Lee K, Nienow AW, Thomas RJ, Smith M, Thomas CR (2011) Expansion of human mesenchymal stem cells on microcarriers. Biotechnol Lett 33:2325–2335. https://doi.org/10.1007/s10529-011-0695-4
Yourek G, McCormick SM, Mao JJ, Reilly GC (2010) Shear stress induces osteogenic differentiation of human mesenchymal stem cells. Regen Med 5:713–724. https://doi.org/10.2217/rme.10.60
Yourek G, Hussain MA, Mao JJ (2007) Cytoskeletal changes of mesenchymal stem cells during differentiation. ASAIO J 53:219–228. https://doi.org/10.1097/MAT.0b013e31802deb2d
Yeatts AB, Choquette DT, Fisher JP (2013) Bioreactors to influence stem cell fate: augmentation of mesenchymal stem cell signaling pathways via dynamic culture systems. Biochim Biophys Acta Gen Subj 1830:2470–2480. https://doi.org/10.1016/j.bbagen.2012.06.007
Yeatts AB, Fisher JP (2011) Bone tissue engineering bioreactors: dynamic culture and the influence of shear stress. Bone 48:171–181. https://doi.org/10.1016/j.bone.2010.09.138
Weyand B, Reimers K, Vogt PM (2011) Influences of extracellular matrix properties and flow shear stresses on stem cell shape in a three-dimensional dynamic environment. IFMBE Proc 30:47–50
Weyand B, Kasper C, Israelowitz M, Gille C, von Schroeder HP, Reimers K, Vogt PM (2012) A differential pressure laminar flow reactor supports osteogenic differentiation and extracellular matrix formation from adipose mesenchymal stem cells in a macroporous ceramic scaffold. Biores Open Access 1:145–157
Weyand B, Israelowitz M, von Schroeder HP, Vogt PM (2009) Fluid dynamics in bioreactor design: considerations for the theoretical and practical approach. Adv Biochem Eng Biotechnol 112:251–268
Croughan MS, Hamel J-F, Wang DIC (2006) Hydrodynamic effects on animal cells grown in microcarrier cultures. Biotechnol Bioeng 95:295–305. https://doi.org/10.1002/bit.21158
Heathman TRJ, Stolzing A, Fabian C, Rafiq QA, Coopman K, Nienow AW, Kara B, Hewitt CJ (2015) Serum-free process development: improving the yield and consistency of human mesenchymal stromal cell production. Cytotherapy 17:1524–1535. https://doi.org/10.1016/j.jcyt.2015.08.002
Cierpka K, Elseberg CL, Niss K, Kassem M, Salzig D, Czermak P (2013) hMSC production in disposable bioreactors with regards to GMP and PAT. Chem Ing Tech 85:67–75. https://doi.org/10.1002/cite.201200151
Rafiq QA, Hanga MP, Heathman TRJ, Coopman K, Nienow AW, Williams DJ, Hewitt CJ (2017) Process development of human multipotent stromal cell microcarrier culture using an automated high-throughput microbioreactor. Biotechnol Bioeng 114:2253–2266. https://doi.org/10.1002/bit.26359
Higuera G, Schop D, Janssen F, van Dijkhuizen-Radersma R, van Boxtel T, van Blitterswijk CA (2009) Quantifying in vitro growth and metabolism kinetics of human mesenchymal stem cells using a mathematical model. Tissue Eng Part A 15:2653–2663. https://doi.org/10.1089/ten.tea.2008.0328
dos Santos F, Andrade PZ, Boura JS, Abecasis MM, da Silva CL, Cabral JMS (2009) Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia. J Cell Physiol 223:n/a–n/a. https://doi.org/10.1002/jcp.21987
Bartolini E, Manoli H, Costamagna E, Jeyaseelan HA, Hamad M, Irhimeh MR, Khademhosseini A, Abbas A (2015) Population balance modelling of stem cell culture in 3D suspension bioreactors. Chem Eng Res Des 101:125–134. https://doi.org/10.1016/j.cherd.2015.07.014
Mancuso L, Ilaria Liuzzo M, Fadda S, Cincotti A, Pisu M, Concas A, Cao G (2010) Experimental analysis and modeling of bone marrow mesenchymal stem cells proliferation. Chem Eng Sci 65:562–568. https://doi.org/10.1016/j.ces.2009.06.034
Bailón-Plaza A, van der Meulen MCH (2001) A mathematical framework to study the effects of growth factor influences on fracture healing. J Theor Biol 212:191–209. https://doi.org/10.1006/jtbi.2001.2372
Geris L, Peiffer V, Demol J, Oosterwyck H Van (2006) Modelling of in vitro mesenchymal stem cell cultivation, chondrogenesis and osteogenesis. J Biomech 41:466–466
Schellenberg A, Stiehl T, Horn P, Joussen S, Pallua N, Ho AD, Wagner W (2012) Population dynamics of mesenchymal stromal cells during culture expansion. Cytotherapy 14:401–411. https://doi.org/10.3109/14653249.2011.640669
Cholewa D, Stiehl T, Schellenberg A, Bokermann G, Joussen S, Koch C, Walenda T, Pallua N, Marciniak-Czochra A, Suschek CV, Wagner W (2011) Expansion of adipose mesenchymal stromal cells is affected by human platelet lysate and plating density. Cell Transplant 20:1409–1422. https://doi.org/10.3727/096368910X557218
Hoffmann M, Kuska J-P, Zscharnack M, Loeffler M, Galle J (2011) Spatial organization of mesenchymal stem cells in vitro – results from a new individual cell-based model with podia. PLoS One 6:e21960. https://doi.org/10.1371/journal.pone.0021960
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jossen, V., Eibl, D., Eibl, R. (2020). Numerical Methods for the Design and Description of In Vitro Expansion Processes of Human Mesenchymal Stem Cells. In: Herwig, C., Pörtner, R., Möller, J. (eds) Digital Twins. Advances in Biochemical Engineering/Biotechnology, vol 177. Springer, Cham. https://doi.org/10.1007/10_2020_147
Download citation
DOI: https://doi.org/10.1007/10_2020_147
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-71655-4
Online ISBN: 978-3-030-71656-1
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)